Floatz logo

PECANS

GI Health

Texas Tech University Health Sciences Centerother_biologicalPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the GI Health cohort.

Asset / SponsorPhaseRating
Empagliflozin
Yonsei University
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB

View all 44 →

Same molecule, other indications

PECANS is also rated in:

obesity disorderDormant
D
Indicative ·
30 / 100
View asset →
inherited lipid metabolism disorderDormant
D
Indicative ·
30 / 100
View asset →
nutritional disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →